Jerry S. Lanchbury, Chief Scientific Officer at MYRIAD GENETICS INC (MYGN), sold 166,744 shares at $31.97 ($5.3M) on 2021-06-25, disclosed to the SEC on 2021-06-28.
Open-market sale of $5.3M MYGN by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.61 | 33,372 | $1.1M | 19.8% |
| 2 | $31.61 | 33,372 | $1.1M | 19.8% |
| 3 | $31.97 | 28,640 | $916K | 17.2% |
| 4 | $31.97 | 28,640 | $916K | 17.2% |
| 5 | $32.47 | 21,360 | $694K | 13.0% |
| 6 | $32.47 | 21,360 |
| $694K |
| 13.0% |
| Total | $31.95 avg | 166,744 | $5.3M | 100% |
| Filing → |
| MYGN | SELL | 2021-08-06 | $2.0M | — | Filing → |
| MYGN | SELL | 2021-08-05 | $4.5M | — | Filing → |
| MYGN | SELL | 2021-07-14 | $4.9M | — | Filing → |